vs
Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $39.6M, roughly 1.5× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -1229.6%, a 1265.5% gap on every dollar of revenue. On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-695.9M). Over the past eight quarters, Cipher Mining Inc.'s revenue compounded faster (11.4% CAGR vs -15.0%).
Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CIFR vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $59.7M | $39.6M |
| Net Profit | $-734.2M | $14.2M |
| Gross Margin | 59.4% | 73.1% |
| Operating Margin | -503.4% | 32.5% |
| Net Margin | -1229.6% | 35.9% |
| Revenue YoY | 41.4% | -10.9% |
| Net Profit YoY | -4293.1% | 117.2% |
| EPS (diluted) | $-1.91 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.7M | $39.6M | ||
| Q3 25 | $71.7M | $43.4M | ||
| Q2 25 | $43.6M | $43.4M | ||
| Q1 25 | $49.0M | $47.3M | ||
| Q4 24 | $42.2M | $44.4M | ||
| Q3 24 | $24.1M | $53.1M | ||
| Q2 24 | $36.8M | $53.1M | ||
| Q1 24 | $48.1M | $54.8M |
| Q4 25 | $-734.2M | $14.2M | ||
| Q3 25 | $-3.3M | $12.8M | ||
| Q2 25 | $-45.8M | $2.5M | ||
| Q1 25 | $-39.0M | $21.5M | ||
| Q4 24 | $17.5M | $6.5M | ||
| Q3 24 | $-86.8M | $2.8M | ||
| Q2 24 | $-15.3M | $18.5M | ||
| Q1 24 | $39.9M | $18.8M |
| Q4 25 | 59.4% | 73.1% | ||
| Q3 25 | 62.7% | 70.6% | ||
| Q2 25 | 64.8% | 69.2% | ||
| Q1 25 | 69.6% | 79.7% | ||
| Q4 24 | 56.9% | 76.3% | ||
| Q3 24 | 37.5% | 81.5% | ||
| Q2 24 | 61.2% | 74.2% | ||
| Q1 24 | 69.2% | 72.1% |
| Q4 25 | -503.4% | 32.5% | ||
| Q3 25 | -52.5% | 36.6% | ||
| Q2 25 | -103.9% | 33.6% | ||
| Q1 25 | -77.8% | 51.1% | ||
| Q4 24 | 40.5% | 10.6% | ||
| Q3 24 | -379.2% | 26.1% | ||
| Q2 24 | -43.9% | 51.4% | ||
| Q1 24 | 97.2% | 44.6% |
| Q4 25 | -1229.6% | 35.9% | ||
| Q3 25 | -4.6% | 29.6% | ||
| Q2 25 | -105.1% | 5.7% | ||
| Q1 25 | -79.6% | 45.4% | ||
| Q4 24 | 41.5% | 14.7% | ||
| Q3 24 | -359.9% | 5.3% | ||
| Q2 24 | -41.5% | 34.8% | ||
| Q1 24 | 82.9% | 34.2% |
| Q4 25 | $-1.91 | $0.15 | ||
| Q3 25 | $-0.01 | $0.12 | ||
| Q2 25 | $-0.12 | $0.02 | ||
| Q1 25 | $-0.11 | $0.21 | ||
| Q4 24 | $0.04 | $0.05 | ||
| Q3 24 | $-0.26 | $0.03 | ||
| Q2 24 | $-0.05 | $0.20 | ||
| Q1 24 | $0.13 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $628.3M | $164.1M |
| Total DebtLower is stronger | $2.7B | $42.8M |
| Stockholders' EquityBook value | $805.5M | $248.3M |
| Total Assets | $4.3B | $380.4M |
| Debt / EquityLower = less leverage | 3.37× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $628.3M | $164.1M | ||
| Q3 25 | $1.2B | $127.4M | ||
| Q2 25 | $62.7M | $152.7M | ||
| Q1 25 | $23.2M | $132.1M | ||
| Q4 24 | $5.6M | $125.0M | ||
| Q3 24 | $25.3M | $137.4M | ||
| Q2 24 | $122.6M | — | ||
| Q1 24 | $88.7M | — |
| Q4 25 | $2.7B | $42.8M | ||
| Q3 25 | $1.0B | $21.1M | ||
| Q2 25 | $167.1M | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | $0 | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $805.5M | $248.3M | ||
| Q3 25 | $783.2M | $248.0M | ||
| Q2 25 | $748.9M | $244.6M | ||
| Q1 25 | $734.8M | $226.4M | ||
| Q4 24 | $682.0M | $195.1M | ||
| Q3 24 | $672.0M | $205.0M | ||
| Q2 24 | $690.8M | $8.8M | ||
| Q1 24 | $600.9M | $9.0M |
| Q4 25 | $4.3B | $380.4M | ||
| Q3 25 | $2.8B | $321.4M | ||
| Q2 25 | $1.0B | $315.3M | ||
| Q1 25 | $913.8M | $284.6M | ||
| Q4 24 | $855.4M | $266.1M | ||
| Q3 24 | $775.4M | $296.5M | ||
| Q2 24 | $775.6M | $19.5M | ||
| Q1 24 | $677.1M | $19.8M |
| Q4 25 | 3.37× | 0.17× | ||
| Q3 25 | 1.31× | 0.09× | ||
| Q2 25 | 0.22× | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | 0.00× | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-207.9M | $52.0M |
| Free Cash FlowOCF − Capex | $-695.9M | $51.2M |
| FCF MarginFCF / Revenue | -1165.4% | 129.3% |
| Capex IntensityCapex / Revenue | 817.1% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-1.1B | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-207.9M | $52.0M | ||
| Q3 25 | $-50.1M | $-20.9M | ||
| Q2 25 | $-56.2M | $-8.3M | ||
| Q1 25 | $-47.2M | $1.9M | ||
| Q4 24 | $-87.5M | $-7.3M | ||
| Q3 24 | $-6.5M | $5.0M | ||
| Q2 24 | $-25.4M | $19.2M | ||
| Q1 24 | $-26.6M | $3.7M |
| Q4 25 | $-695.9M | $51.2M | ||
| Q3 25 | $-256.2M | $-20.9M | ||
| Q2 25 | $-87.5M | $-8.6M | ||
| Q1 25 | $-71.8M | $1.7M | ||
| Q4 24 | $-227.0M | $-7.9M | ||
| Q3 24 | $-83.2M | $4.6M | ||
| Q2 24 | $-33.2M | $18.3M | ||
| Q1 24 | $-34.5M | $3.0M |
| Q4 25 | -1165.4% | 129.3% | ||
| Q3 25 | -357.3% | -48.3% | ||
| Q2 25 | -200.9% | -19.9% | ||
| Q1 25 | -146.7% | 3.5% | ||
| Q4 24 | -537.6% | -17.8% | ||
| Q3 24 | -345.0% | 8.7% | ||
| Q2 24 | -90.2% | 34.5% | ||
| Q1 24 | -71.7% | 5.4% |
| Q4 25 | 817.1% | 2.0% | ||
| Q3 25 | 287.5% | 0.1% | ||
| Q2 25 | 71.8% | 0.7% | ||
| Q1 25 | 50.2% | 0.5% | ||
| Q4 24 | 330.4% | 1.3% | ||
| Q3 24 | 317.8% | 0.8% | ||
| Q2 24 | 21.4% | 1.6% | ||
| Q1 24 | 16.4% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | -5.00× | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | -0.67× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIFR
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
